Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03522051
Other study ID # JUST14-4-2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2016
Est. completion date August 20, 2021

Study information

Verified date September 2021
Source Jordan University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many deep carious teeth are treated unnecessarily by root canal therapy, while with using current techniques and advances in compatible dental materials in addition to better understanding of biological response of the dental pulp, many can be treated conservatively via vital pulp therapy procedures.


Description:

Vital pulp therapy is recommended for teeth diagnosed with reversible pulpitis or partially inflamed pulps in which the remaining healthy tissue can be conserved and protected by a biologically active material to generate a hard tissue barrier that seals and protects the pulp from future microbial insult. The aim of this in vivo study is to clinically and radiographically assess the outcome of full pulpotomy using a calcium silicate based material (NeoMTA Plus) in permanent teeth with carious exposure. Ethics approval was obtained from the institutional ethics and research committee, and the patients were informed about details of the treatment and the possible complications. An informed consent was obtained. 120 patients meeting the inclusion criteria will be selected for this study and they will be subsequently followed up clinically and radiographically after 3 months, 6 months, 1 year and yearly afterward for 5 years.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date August 20, 2021
Est. primary completion date June 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 80 Years
Eligibility Inclusion Criteria: - Permanent teeth with mature or immature apices - Have no significant medical problems - The tooth should give positive response to cold test and electric pulp test (EPT) - Probing pocket depth and mobility within normal limits - No Signs of pulp necrosis including sinus tract or swelling - Radiographically ; caries either exposing the pulps or reaching more than 2\3 the distance from the dentino-enamel junction (DEJ) to the pulp - The tooth can be restored via direct restoration Exclusion Criteria: - Medically compromised patients - Negative response to cold test - Mobility - Sinus tract - Swelling - Non restorable teeth or badly broken teeth

Study Design


Related Conditions & MeSH terms


Intervention

Other:
calcium silicate based material,
Its a dental pulp capping material which is biocompatable and induces hard tissue barrier formation

Locations

Country Name City State
Jordan Jordan University of science and technology Irbid

Sponsors (1)

Lead Sponsor Collaborator
Jordan University of Science and Technology

Country where clinical trial is conducted

Jordan, 

References & Publications (3)

Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis. Int Endod J. 2018 Aug;51(8):819-828. doi: 10.1111/iej.12903. Epub 2018 Feb 27. — View Citation

Taha NA, Ahmad MB, Ghanim A. Assessment of Mineral Trioxide Aggregate pulpotomy in mature permanent teeth with carious exposures. Int Endod J. 2017 Feb;50(2):117-125. doi: 10.1111/iej.12605. Epub 2016 Jan 30. — View Citation

Taha NA, Khazali MA. Partial Pulpotomy in Mature Permanent Teeth with Clinical Signs Indicative of Irreversible Pulpitis: A Randomized Clinical Trial. J Endod. 2017 Sep;43(9):1417-1421. doi: 10.1016/j.joen.2017.03.033. Epub 2017 Jun 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pain symptoms The patient is anticipated to report reduction in the pain score after receiving the treatment within 2-3 days and the tooth should continue to be asymptomatic at follow up appointments. The patient will be asked to score the pain level on visual analogue scale using a score from 0-10. The zero is no pain while 10 is the maximum level. 2-3 days after the treatment, 3 months, 6 months and 12 months and afterwards up to 5 years.
Secondary Periapical normalcy at follow up radiographs . Pr-existing pathology should heal within 6 months- 1 year and normalcy should be maintained after ward up to 5 years.
no emerging pathosis should be evident in the roots or surrounding bone.
6months , 1 year, 2, 3,4,5 years
Secondary The tooth and restoration should be present in the mouth The tooth should be in the mouth and in function (not extracted) with an intact restoration at the follow up times 3, 6 months, 1 year, 2, 3,4,5 years
See also
  Status Clinical Trial Phase
Withdrawn NCT01878851 - Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.
Completed NCT04270318 - Sodium Hypoclorite as an Antibacterial Agent Prior to Pulpotomies N/A
Completed NCT04909827 - 3D-printed Endocrowns Versus Prefabricated Zirconia Crowns in Pulpally-treated Primary Molars Phase 4
Completed NCT03200938 - Clinical Applicability of PBS® CIMMO Cement in Pulpotomies N/A
Recruiting NCT04863222 - Clinical and Radiographic Success of MTA vs Biodentine Phase 4
Active, not recruiting NCT05554952 - Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries N/A
Completed NCT03779698 - BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars Phase 4
Completed NCT03395496 - Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up Early Phase 1
Not yet recruiting NCT05747300 - Wellroot PT Versus MTA in Pulpotomy of Primary Molars N/A
Not yet recruiting NCT06288477 - Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol N/A
Not yet recruiting NCT06219824 - Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars Phase 3
Completed NCT03718676 - Pulpotomy With Various MTA Materials and Ferric Sulphate N/A
Recruiting NCT05279820 - Comparative Study of the Outcome of Partial and Full Pulpotomy in Irreversible Pulpits N/A
Active, not recruiting NCT02298504 - Vital Pulp Treatment in Primary Teeth Phase 4
Completed NCT04010929 - Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy N/A
Terminated NCT02783911 - Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies N/A
Withdrawn NCT02393326 - Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars N/A
Completed NCT05792748 - Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth N/A
Completed NCT05680285 - Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment N/A
Completed NCT05297344 - Clinical Study of the Direct Pulp Capping in Primary Teeth N/A